Results 191 to 200 of about 260,030 (390)

Approaches to Enhance Photodynamic Therapy of Lung Cancer: Potential Application of Nanoparticles

open access: yesAdvanced NanoBiomed Research, EarlyView.
Bioactive ligand‐targeted nanocarriers can accommodate functionalization with numerous targeting ligands for effective delivery of photosensitizers (PSs) within targeted photodynamic therapy. Various targeting moieties including peptides, antibodies, carbohydrates, aptamers, proteins, and PS anticancer molecules can be attached to nanomaterials.
Nokuphila Winifred Nompumelelo Simelane   +1 more
wiley   +1 more source

Metabolism‐Regulating Nanomedicines for Cancer Therapy

open access: yesAdvanced NanoBiomed Research, EarlyView.
This review highlights metabolism‐regulating nanomedicines designed to target glycolytic, lipid, amino acid, and nucleotide pathways in tumors. By incorporating metabolism‐regulating agents into versatile nanocarriers such as liposomes, micelles, dendrimers, and engineered bacteria, these platforms achieve targeted delivery, controlled release ...
Xiao Wu, Shiyi Geng, Jian Yang
wiley   +1 more source

BRAF and KRAS mutations in prostatic adenocarcinoma [PDF]

open access: bronze, 2006
Nam‐Yun Cho   +5 more
openalex   +1 more source

De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features [PDF]

open access: green, 2007
O Søvik   +8 more
openalex   +1 more source

Penelitian pembuatan motif “batik remukan” pada kulit kras samak krom

open access: diamond, 1992
Meiyanti Meiyanti   +3 more
openalex   +2 more sources

Activation of ERK1/2 occurs independently of KRAS or BRAF status in endometrial cancer and is associated with favorable prognosis [PDF]

open access: hybrid, 2007
Yasunari Mizumoto   +8 more
openalex   +1 more source

Not All KRAS is the Same: Shifting from the Overall KRAS Status to Exon, Codon, and Point KRAS Mutations [PDF]

open access: yesHPB, 2021
P.B. Olthof   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy